We are live on ! Find out more
DCMM

DG Capital Management (Massachusetts) Portfolio holdings

AUM $102M
1-Year Est. Return 29.14%
This Fund
S&P 500
This Quarter Est. Return
-6.06%
1 Year Est. Return
+29.14%
3 Year Est. Return
+96.74%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$148M
AUM Growth
-$17.5M
Cap. Flow
-$4.2M
Cap. Flow %
-2.83%
Top 10 Hldgs %
32.85%
Holding
81
New
16
Increased
25
Reduced
25
Closed
15

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.23M
2
ISRG icon
Intuitive Surgical
ISRG
+$2.43M
3
TCOM icon
Trip.com Group
TCOM
+$2.25M
4
TJX icon
TJX Companies
TJX
+$2.15M
5
AMZN icon
Amazon
AMZN
+$2M

Top Sells

Rank Stock Value
1
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$3.28M
2
PARA
Paramount Global Class B
PARA
+$2.8M
3
BIIB icon
Biogen
BIIB
+$2.66M
4
MON
Monsanto Co
MON
+$2.39M
5
NXPI icon
NXP Semiconductors
NXPI
+$2.35M

Sector Composition

Rank Sector Weight
1 Healthcare 40.2%
2 Financials 15.79%
3 Consumer Discretionary 15.09%
4 Technology 8.11%
5 Communication Services 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.07T
$5.85M 3.94%
69,950
-7,485
-10% -$632K
ADBE icon
2
Adobe
ADBE
$89.5B
$5.49M 3.7%
66,814
+18,875
+39% +$1.53M
AMZN icon
3
Amazon
AMZN
$2.5T
$5.33M 3.59%
208,200
+79,100
+61% +$2M
GILD icon
4
Gilead Sciences
GILD
$161B
$5.04M 3.39%
51,285
+12,885
+34% +$1.43M
NKE icon
5
Nike
NKE
$61.9B
$5.03M 3.39%
81,814
+5,272
+7% +$298K
AMGN icon
6
Amgen
AMGN
$203B
$4.94M 3.32%
35,685
+5,400
+18% +$851K
V icon
7
Visa
V
$677B
$4.87M 3.28%
69,858
-797
-1% -$56.9K
MA icon
8
Mastercard
MA
$477B
$4.82M 3.25%
53,460
+8,115
+18% +$762K
NVS icon
9
Novartis
NVS
$295B
$3.75M 2.53%
45,544
-296
-0.6% -$26.3K
AGN
10
DELISTED
Allergan plc
AGN
$3.67M 2.47%
13,483
+2,595
+24% +$797K
ABBV icon
11
AbbVie
ABBV
$458B
$3.56M 2.4%
65,375
+2,725
+4% +$177K
META icon
12
Meta Platforms (Facebook)
META
$1.51T
$3.48M 2.35%
38,768
+5,290
+16% +$485K
BIIB icon
13
Biogen
BIIB
$29.9B
$3.44M 2.32%
11,804
-8,070
-41% -$2.66M
GOOG icon
14
Alphabet (Google) Class C
GOOG
$3.9T
$3.32M 2.24%
106,520
+37,300
+54% +$1.15M
BMY icon
15
Bristol-Myers Squibb
BMY
$127B
$3.06M 2.06%
51,695
-12,210
-19% -$775K
SPY icon
16
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$3.05M 2.05%
+15,915
New +$3.23M
GS icon
17
Goldman Sachs
GS
$313B
$2.98M 2.01%
17,175
-890
-5% -$175K
SBUX icon
18
Starbucks
SBUX
$118B
$2.81M 1.9%
49,509
+22,979
+87% +$1.29M
BMRN icon
19
BioMarin Pharmaceuticals
BMRN
$11.5B
$2.75M 1.85%
26,130
+1,785
+7% +$238K
BHC icon
20
Bausch Health
BHC
$1.65B
$2.75M 1.85%
15,395
+2,775
+22% +$647K
HDB icon
21
HDFC Bank
HDB
$119B
$2.73M 1.84%
178,768
+31,420
+21% +$474K
DAL icon
22
Delta Air Lines
DAL
$55.9B
$2.55M 1.72%
56,890
+1,080
+2% +$48.5K
JAZZ icon
23
Jazz Pharmaceuticals
JAZZ
$15.9B
$2.54M 1.71%
19,132
+4,001
+26% +$689K
MS icon
24
Morgan Stanley
MS
$337B
$2.54M 1.71%
80,570
+9,880
+14% +$360K
BUD icon
25
AB InBev
BUD
$158B
$2.53M 1.7%
23,765
+4,050
+21% +$470K
1
2 3 4

Similar funds

LOT
Lombard Odier Transatlantic Montreal, Quebec, Canada $105M AUM 10.28% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
PCM
Panning Capital Management New York $97.5M AUM 302.5% 1-Year Est. Return
EDRAML
Edmond de Rothschild Asset Management (Luxembourg) Luxembourg $95.2M AUM 19.45% 1-Year Est. Return
EC
Eachwin Capital New York $108M AUM 14.45% 1-Year Est. Return
SAMNY
Samsung Asset Management (New York) New York $109M AUM 14.34% 1-Year Est. Return
BCCM
Blue Clay Capital Management Minneapolis, Minnesota $88.7M AUM 6.88% 1-Year Est. Return
EIAM
Equinox Institutional Asset Management Princeton, New Jersey $87.9M AUM 1.01% 1-Year Est. Return

DG Capital Management (Massachusetts)'s Q3 2015 Portfolio in Review

As of Q3 2015, DG Capital Management (Massachusetts) held 81 positions worth $148M, down 11% from $166M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

DG Capital Management (Massachusetts)'s Q3 2015 filing shows 16 new, 25 increased, 25 reduced and 15 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 15,915 shares worth $3.05M. The largest sale was RECEPTOS INC COM STK (DE), an estimated $3.28M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 39% a quarter earlier, followed by Financials and Consumer Discretionary.

  • DG Capital Management (Massachusetts)'s largest Q3 2015 buy was State Street SPDR S&P 500 ETF Trust: 15,915 shares worth $3.05M.
  • DG Capital Management (Massachusetts) added most to Amazon in Q3 2015, an estimated $2M increase.
  • DG Capital Management (Massachusetts)'s biggest Q3 2015 reduction was Biogen, cutting an estimated $2.66M.
  • DG Capital Management (Massachusetts) fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $3.28M.
  • DG Capital Management (Massachusetts)'s ten largest holdings make up 33% of its $148M portfolio in Q3 2015.
  • DG Capital Management (Massachusetts) opened 16 new positions and closed 15 in Q3 2015.
  • DG Capital Management (Massachusetts)'s portfolio value fell 11% quarter-over-quarter to $148M.

Based on DG Capital Management (Massachusetts)'s 13F filing for Q3 2015, filed 10 Nov 2015.